Entourage Health Corp. (ETRGF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Entourage Health Corp. (ETRGF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 35/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Entourage Health Corp. (ETRGF) Gesundheitswesen & Pipeline-Uebersicht
Entourage Health Corp. is a Canadian cannabis producer serving the medical and adult-use markets, offering a range of cannabis products under brands like Color Cannabis and Saturday Cannabis. Facing a competitive landscape and evolving regulatory environment, Entourage focuses on product innovation and market expansion within Canada's cannabis sector.
Investmentthese
Entourage Health Corp. faces a challenging market environment with a negative profit margin of -113.4% and a low gross margin of 9.1%. The company's high beta of 1.81 suggests significant volatility relative to the market. Growth catalysts include potential expansion of its product lines and increased market penetration within Canada. However, investors should be aware of the risks associated with operating in a highly regulated and competitive industry. The company's ability to improve its financial performance and capitalize on growth opportunities will be critical to its long-term success.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of -0.03 suggests the company is not currently profitable.
- Profit Margin of -113.4% highlights significant challenges in achieving profitability.
- Gross Margin of 9.1% indicates a low margin on sales after accounting for the cost of goods sold.
- Beta of 1.81 suggests the stock is more volatile than the overall market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Established brands in the Canadian cannabis market.
- Diverse product portfolio catering to various consumer segments.
- Expertise in cannabis cultivation and processing.
- Strategic partnerships with retailers and distributors.
Schwaechen
- Negative profit margin and low gross margin.
- High beta indicating significant stock volatility.
- Limited geographic reach primarily focused on Canada.
- Dependence on regulatory approvals and compliance.
Katalysatoren
- Upcoming: Potential regulatory changes in Canada that could expand the cannabis market.
- Ongoing: Expansion of product offerings to include new cannabis-infused products.
- Ongoing: Increased market penetration through strategic partnerships and distribution agreements.
Risiken
- Potential: Intense competition from other cannabis producers.
- Ongoing: Evolving regulations and compliance requirements.
- Ongoing: Price pressures and margin erosion.
- Potential: Changing consumer preferences and market trends.
- Ongoing: Limited access to capital and financing options.
Wachstumschancen
- Expansion of Product Lines: Entourage Health Corp. can expand its product lines to include new and innovative cannabis products, such as infused beverages, concentrates, and wellness products. The market for cannabis-infused products is growing, offering opportunities to cater to diverse consumer preferences. The timeline for product development and launch is approximately 6-12 months, with a potential market size of $500 million annually.
- Increased Market Penetration in Canada: Entourage can increase its market penetration by expanding its distribution network and retail presence across Canada. This includes establishing partnerships with retailers, opening new dispensaries, and leveraging e-commerce platforms. The Canadian cannabis market is projected to reach $5 billion by 2027, offering significant growth opportunities.
- Strategic Partnerships and Acquisitions: Entourage can pursue strategic partnerships and acquisitions to expand its capabilities, market reach, and product portfolio. This includes partnering with other cannabis companies, technology providers, or research institutions. Strategic alliances can provide access to new markets, technologies, and expertise, accelerating growth and innovation.
- Focus on Medical Cannabis Market: Entourage can focus on expanding its presence in the medical cannabis market by developing specialized products and services for patients with specific medical conditions. This includes conducting clinical research, collaborating with healthcare professionals, and providing educational resources for patients. The medical cannabis market offers opportunities for higher margins and long-term customer relationships.
- Development of Proprietary Cannabis Strains: Entourage can invest in the development of proprietary cannabis strains with unique characteristics, such as high THC or CBD content, specific terpene profiles, or enhanced therapeutic effects. Proprietary strains can differentiate the company's products and create a competitive advantage in the market. The development process typically takes 12-18 months, with a potential market value of $100 million annually.
Chancen
- Expansion into new product categories, such as infused beverages and wellness products.
- Increased market penetration in Canada through expanded distribution.
- Strategic partnerships and acquisitions to enhance capabilities.
- Focus on the medical cannabis market with specialized products.
Risiken
- Intense competition from other cannabis producers.
- Evolving regulations and compliance requirements.
- Price pressures and margin erosion.
- Changing consumer preferences and market trends.
Wettbewerbsvorteile
- Brand recognition through established brands like Color Cannabis and Starseed Medicinals.
- Proprietary cannabis strains and formulations.
- Established distribution network and retail partnerships.
- Expertise in cannabis cultivation, processing, and manufacturing.
Ueber ETRGF
Entourage Health Corp., formerly known as WeedMD Inc., is a Canadian cannabis company that cultivates, processes, and distributes a diverse range of cannabis products. Founded with the vision of providing high-quality cannabis for medical and recreational use, the company has evolved to become a player in the Canadian cannabis market. Entourage offers cannabis plants, dried cannabis, oils, topicals, extracts, and edibles, catering to various consumer preferences and medical needs. The company's products are marketed under several brands, including Color Cannabis, known for its recreational appeal; Saturday Cannabis, targeting a specific consumer segment; Starseed Medicinals, focused on the medical cannabis market; and Mary's Medicinals, offering a range of wellness-focused products. Entourage Health Corp. operates primarily within Canada, focusing on expanding its market share and product offerings in the Canadian cannabis landscape. The company is headquartered in Toronto, Canada, and continues to adapt to the evolving regulatory environment and consumer demands within the cannabis industry.
Was das Unternehmen tut
- Cultivates cannabis plants for medical and adult-use markets.
- Processes cannabis into various product formats, including dried cannabis, oils, and extracts.
- Manufactures cannabis-infused products such as edibles and topicals.
- Distributes cannabis products through various channels, including retail stores and online platforms.
- Markets and sells cannabis products under various brand names, including Color Cannabis and Starseed Medicinals.
- Conducts research and development to innovate new cannabis products and formulations.
Geschaeftsmodell
- Cultivation and production of cannabis.
- Processing and manufacturing of cannabis products.
- Distribution and sale of cannabis products through retail and wholesale channels.
- Branding and marketing of cannabis products to consumers.
Branchenkontext
Entourage Health Corp. operates within the rapidly evolving Canadian cannabis industry. The market is characterized by increasing competition, evolving regulations, and shifting consumer preferences. While the industry offers significant growth potential, companies face challenges related to regulatory compliance, pricing pressures, and brand differentiation. Entourage competes with other licensed producers in Canada, striving to capture market share through product innovation, strategic partnerships, and effective marketing strategies. The industry is also subject to ongoing regulatory changes that can impact production, distribution, and marketing practices.
Wichtige Kunden
- Adult-use cannabis consumers seeking recreational products.
- Medical cannabis patients seeking therapeutic relief.
- Retail dispensaries and cannabis stores.
- Wholesale distributors and partners.
Finanzdaten
Chart & Info
Entourage Health Corp. (ETRGF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer ETRGF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ETRGF.
Kursziele
Wall-Street-Kurszielanalyse fuer ETRGF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von ETRGF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: George Scorsis
CEO
George Scorsis is an experienced executive with a background in the beverage and cannabis industries. Prior to joining Entourage Health Corp., he held leadership positions at various companies, including Liberty Health Sciences and Aphria Inc. His experience includes strategic planning, business development, and operational management. Scorsis has a track record of driving growth and innovation in highly regulated industries.
Erfolgsbilanz: Since becoming CEO, George Scorsis has focused on streamlining operations, expanding product offerings, and strengthening the company's market position. Key milestones under his leadership include the rebranding of WeedMD Inc. to Entourage Health Corp. and the launch of new cannabis products. Scorsis has also emphasized strategic partnerships and acquisitions to drive growth and enhance shareholder value.
ETRGF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Entourage Health Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, regulatory oversight, and investor protection compared to those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks involves higher risks due to the potential for limited information and liquidity.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- Higher price volatility due to low trading volume.
- Potential for wider bid-ask spreads and execution challenges.
- Increased risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor.
- Understand the risks associated with OTC investing.
- Established brands in the Canadian cannabis market.
- Operations in a regulated industry (cannabis).
- Experienced management team.
- Publicly traded status, even on the OTC market.
- Presence of a functioning website and investor relations materials.
Haeufige Fragen zu ETRGF
What are the key factors to evaluate for ETRGF?
Entourage Health Corp. (ETRGF) currently holds an AI score of 35/100, indicating low score. Key strength: Established brands in the Canadian cannabis market.. Primary risk to monitor: Potential: Intense competition from other cannabis producers.. This is not financial advice.
How frequently does ETRGF data refresh on this page?
ETRGF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ETRGF's recent stock price performance?
Recent price movement in Entourage Health Corp. (ETRGF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands in the Canadian cannabis market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ETRGF overvalued or undervalued right now?
Determining whether Entourage Health Corp. (ETRGF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ETRGF?
Before investing in Entourage Health Corp. (ETRGF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ETRGF to a portfolio?
Potential reasons to consider Entourage Health Corp. (ETRGF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established brands in the Canadian cannabis market.. Additionally: Diverse product portfolio catering to various consumer segments.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of ETRGF?
Yes, most major brokerages offer fractional shares of Entourage Health Corp. (ETRGF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ETRGF's earnings and financial reports?
Entourage Health Corp. (ETRGF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ETRGF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on publicly available information and may be subject to limitations.
- OTC market data may be less reliable than data from major exchanges.
- Analyst coverage is limited due to the company's OTC listing and small market capitalization.